14-94382724-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting

The NM_000295.5(SERPINA1):​c.514G>A​(p.Gly172Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000395 in 1,614,258 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G172W) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00033 ( 2 hom. )

Consequence

SERPINA1
NM_000295.5 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: -1.46
Variant links:
Genes affected
SERPINA1 (HGNC:8941): (serpin family A member 1) The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.034241676).
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SERPINA1NM_000295.5 linkc.514G>A p.Gly172Arg missense_variant Exon 2 of 5 ENST00000393087.9 NP_000286.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SERPINA1ENST00000393087.9 linkc.514G>A p.Gly172Arg missense_variant Exon 2 of 5 1 NM_000295.5 ENSP00000376802.4 P01009-1

Frequencies

GnomAD3 genomes
AF:
0.00100
AC:
153
AN:
152248
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00292
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000346
AC:
87
AN:
251480
Hom.:
0
AF XY:
0.000302
AC XY:
41
AN XY:
135914
show subpopulations
Gnomad AFR exome
AF:
0.00166
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000440
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000330
AC:
482
AN:
1461892
Hom.:
2
Cov.:
31
AF XY:
0.000329
AC XY:
239
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.00242
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000252
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000286
Gnomad4 OTH exome
AF:
0.000927
GnomAD4 genome
AF:
0.00102
AC:
156
AN:
152366
Hom.:
0
Cov.:
33
AF XY:
0.000980
AC XY:
73
AN XY:
74512
show subpopulations
Gnomad4 AFR
AF:
0.00298
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000323
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.0000284
Hom.:
0
Bravo
AF:
0.000926
ExAC
AF:
0.000428
AC:
52
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.00104
EpiControl
AF:
0.00113

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Alpha-1-antitrypsin deficiency Uncertain:4Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

May 28, 2019
Mendelics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 08, 2014
Department of Laboratory Medicine and Genetics, Trillium Health Partners Credit Valley Hospital
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: curation

- -

Jan 12, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Dec 28, 2017
Counsyl
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Uncertain:1
Feb 02, 2018
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.18
CADD
Benign
0.019
DANN
Benign
0.33
DEOGEN2
Benign
0.12
T;T;T;T;T;T;T;T;T;.;.
Eigen
Benign
-1.9
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.072
.;.;.;T;.;.;.;.;.;T;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.034
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
-0.56
N;N;N;N;N;N;N;N;N;N;.
PrimateAI
Benign
0.22
T
PROVEAN
Benign
1.5
N;N;N;N;N;.;N;N;N;N;N
REVEL
Uncertain
0.47
Sift
Benign
0.93
T;T;T;T;T;.;T;T;T;T;T
Sift4G
Benign
1.0
T;T;T;T;T;.;T;T;T;T;.
Polyphen
0.0
B;B;B;B;B;B;B;B;B;B;.
Vest4
0.12
MutPred
0.69
Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);Gain of catalytic residue at G172 (P = 0.0061);.;
MVP
0.72
MPC
0.050
ClinPred
0.0016
T
GERP RS
-4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.21
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs112030253; hg19: chr14-94849061; COSMIC: COSV63345385; COSMIC: COSV63345385; API